Cargando…
ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
BACKGROUND: Systemic sclerosis (SSc), with unclear pathophysiology, is a paradigmatic rheumatic disease of immunity dysfunction-driven multi-organ inflammation and ultimate fibrosis. Pathogenesis breakthroughs are urgently needed for available treatments halting its unremitting stiffness. This study...
Autores principales: | Cao, Dianyu, Zheng, Jina, Li, Zheng, Yu, Yong, Chen, Zengrui, Wang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601156/ https://www.ncbi.nlm.nih.gov/pubmed/37884942 http://dx.doi.org/10.1186/s13075-023-03190-9 |
Ejemplares similares
-
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
por: Pei, Zhuo, et al.
Publicado: (2022) -
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022) -
Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
por: Fan, Zhenyu, et al.
Publicado: (2021) -
Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
por: Xia, Huawei, et al.
Publicado: (2021) -
Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice
por: Li, Li, et al.
Publicado: (2018)